CD44 and neoplasm: A recent study has shown that CD24−/CD44+ CSCs were associated with cell proliferation and tumor progression, whereas ALDH+ CSCs were more associated with metastasis, indicating that these two markers enrich for different CSC populations with diverse phenotypes [30].